Committee for Orphan Medicinal Products (COMP): 13-15 June 2017

Date

Tuesday, 13 June 2017, All day

Location

European Medicines Agency, Amsterdam, the Netherlands

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

Documents

Share this page